Crossmark

Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?

Crossref DOI link: https://doi.org/10.1245/s10434-022-12626-6

Published Online: 2022-10-10

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Knape, Nicole

Park, Ji-Hye

Agala, Chris B.

Spanheimer, Philip

Morrow, Monica

Downs-Canner, Stephanie https://orcid.org/0000-0002-6870-3285
Baldwin, Xavier L.
Funding

Funding for this research was provided by:

National Cancer Institute (1T32CA211056-01A1, 5K12CA120780-12)

National Institute of Diabetes and Digestive and Kidney Diseases (T35-DK007386)
License Information

Text and Data Mining valid from 2022-10-10

Version of Record valid from 2022-10-10
More Information

Article History

Received: 26 July 2022

Accepted: 13 September 2022

First Online: 10 October 2022

Disclosures

: The authors declare no conflicts of interest.

Document is current

Any future updates will be listed below